Usefulness of diurnal variation of fractional exhaled nitric oxide for predicting early therapeutic response to asthma treatment

References

• Cazzoletti L, Marcon A, Janson C, Corsico A, Jarvis D, Pin I, Accordini S, Almar E, Bugiani M, Carolei A, et al. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol. 2007;120(6):1360–1367. [PubMed: 17981317] doi:10.1016/j.jaci.2007.09.019.
   PubMed Web of Science ®Google Scholar
• Global Strategy for Asthma Management and Prevention. Global strategy for asthma management and prevention (GINA) 2020. Available at: www.ginasthma.org. [accessed 2020 June 23].
   Google Scholar
• Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin AC, Plummer AL, Taylor DA. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602–615. [PubMed: 21885636] doi:10.1164/rccm.9120-11ST.
   PubMed Web of Science ®Google Scholar
• Saito J, Sato S, Hasunuma H, Ishimaru Y, Kanegae H, Kudo S, Munakata M. Off-line fractional exhaled nitric oxide measurement is useful to screen allergic airway inflammation in an adult population. J Asthma. 2007;44(10):805–810. [PubMed: 18097854] doi:10.1080/02770900701645595.
   PubMed Web of Science ®Google Scholar
• Sato S, Saito J, Sato Y, Ishii T, Xintao W, Tanino Y, Ishida T, Munakata M. Clinical usefulness of fractional exhaled nitric oxide for diagnosing prolonged cough. Respir Med. 2008;102(10):1452–1459. [PubMed: 18614345] doi:10.1016/j.rmed.2008.04.018.
   PubMed Web of Science ®Google Scholar
• Fukuhara A, Saito J, Sato S, Sato Y, Nikaido T, Saito K, Fukuhara-Nakagawa N, Inokoshi Y, Ishii T, Tanino Y, et al. Validation study of asthma screening criteria based on subjective symptoms and fractional exhaled nitric oxide. Ann Allergy Asthma Immunol. 2011;107(6):480–486. [PubMed: 22123376] doi:10.1016/j.anai.2011.09.002.
   PubMed Web of Science ®Google Scholar
• Holguin F, Cardet JC, Chung KF, Diver S, Ferreira DS, Fitzpatrick A, Gaga M, Kellermeyer L, Khurana S, Knight S, et al. Management of severe asthma: a European Respiratory Society/American thoracic society guideline. Eur Respir J. 2020;55(1):1900588–31558662. [PubMed: doi:10.1183/13993003.00588-2019.
   PubMed Web of Science ®Google Scholar
• Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 2005;352(21):2163–2173. [PubMed: 15914548] doi:10.1056/NEJMoa043596.
   PubMed Web of Science ®Google Scholar
• Powell H, Murphy VE, Taylor DR, Hensley MJ, McCaffery K, Giles W, Clifton VL, Gibson PG. Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial. Lancet. 2011;378(9795):983–990. [PubMed: 21907861] doi:10.1016/S0140-6736(11)60971-9.
   PubMed Web of Science ®Google Scholar
• Szefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O’Connor GT, Morgan WJ, Kattan M, Pongracic JA, Teach SJ, Bloomberg GR, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet. 2008;372(9643):1065–1072. [PubMed: 18805335] doi:10.1016/S0140-6736(08)61448-8.
   PubMed Web of Science ®Google Scholar
• de Jongste JC, Carraro S, Hop WC, Baraldi E. Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. Am J Respir Crit Care Med. 2009;179(2):93–97. [PubMed: 18931330] doi:10.1164/rccm.200807-1010OC.
   PubMed Web of Science ®Google Scholar
• Anderson WJ, Short PM, Williamson PA, Lipworth BJ. Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENOtype trial. Chest. 2012;142(6):1553–1561. [PubMed: 23364390] doi:10.1378/chest.12-1310.
   PubMed Web of Science ®Google Scholar
• Saito J, Gibeon D, Macedo P, Menzies-Gow A, Bhavsar PK, Chung KF. Domiciliary diurnal variation of exhaled nitric oxide fraction for asthma control. Eur Respir J. 2014;43(2):474–484. [PubMed: 23949962] doi:10.1183/09031936.00048513.
   PubMed Web of Science ®Google Scholar
• Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, Hallstrand TS, Kaminsky DA, McCarthy K, McCormack MC, et al. Standardization of spirometry 2019 update. an official American thoracic society and European respiratory society technical statement. Am J Respir Crit Care Med. 2019;200(8):e70–e88. [PubMed: 31613151]. doi:10.1164/rccm.201908-1590ST.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912–930. [PubMed: 15817806]
   PubMed Web of Science ®Google Scholar
• Baraldi E, Azzolin NM, Dario C, Carra S, Ongaro R, Biban P, Zacchello F. Effect of atmospheric nitric oxide (NO) on measurements of exhaled NO in asthmatic children. Pediatr Pulmonol. 1998;26(1):30–34. [PubMed: 9710277] doi:10.1002/(SICI)1099-0496(199807)26:1<30::AID-PPUL6>3.0.CO;2-M.
   PubMed Web of Science ®Google Scholar
• Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med. 1996;154(5):1505–1510. [PubMed: 8912772] doi:10.1164/ajrccm.154.5.8912772.
   PubMed Web of Science ®Google Scholar
• Kraft M, Martin RJ, Wilson S, Djukanovic R, Holgate ST. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am J Respir Crit Care Med. 1999;159(1):228–234. [PubMed: 9872843] doi:10.1164/ajrccm.159.1.9804033.
   PubMed Web of Science ®Google Scholar
• Blumberg MZ, Buckley JM. The total eosinophil count and adrenal function in asthmatic children. Ann Allergy. 1975; 35(6):377–381. [PubMed: 1200425]
   PubMedGoogle Scholar
• Nakamura Y, Harama D, Shimokawa N, Hara M, Suzuki R, Tahara Y, Ishimaru K, Katoh R, Okumura K, Ogawa H, et al. Circadian clock gene Period2 regulates a time-of-day-dependent variation in cutaneous anaphylactic reaction. J Allergy Clin Immunol. 2011;127(4):1038–1045.e1-3. [PubMed: 21458659] doi:10.1016/j.jaci.2011.02.006.
   PubMed Web of Science ®Google Scholar
• Barnes P, FitzGerald G, Brown M, Dollery C. Nocturnal asthma and changes in circulating epinephrine, histamine, and cortisol. N Engl J Med. 1980. 303(5):263–267. [PubMed: 6247655]
   PubMed Web of Science ®Google Scholar
• Durrington HJ, Gioan-Tavernier GO, Maidstone RJ, Krakowiak K, Loudon ASI, Blaikley JF, Fowler SJ, Singh D, Simpson A, Ray DW. Time of day affects eosinophil biomarkers in asthma: implications for diagnosis and treatment. Am J Respir Crit Care Med. 2018;198(12):1578–1581. [PubMed: 30156881] doi:10.1164/rccm.201807-1289LE.
   PubMed Web of Science ®Google Scholar
• Burkhart PV, Rayens MK, Revelette WR, Ohlmann A. Improved health outcomes with peak flow monitoring for children with asthma. J Asthma. 2007;44(2):137–142. [PubMed: 17454329] doi:10.1080/02770900601182517.
   PubMed Web of Science ®Google Scholar
• Janson SL, McGrath KW, Covington JK, Baron RB, Lazarus SC. Objective airway monitoring improves asthma control in the cold and flu season: a cluster randomized trial. Chest. 2010;138(5):1148–1155. [PubMed: 20538819] doi:10.1378/chest.09-2394.
   PubMed Web of Science ®Google Scholar
• Adams RJ, Boath K, Homan S, Campbell DA, Ruffin RE. A randomized trial of peak-flow and symptom-based action plans in adults with moderate-to-severe asthma. Respirology. 2001;6(4):297–304. [PubMed: 11844120] doi:10.1046/j.1440-1843.2001.00350.x.
   PubMedGoogle Scholar
• Buist AS, Vollmer WM, Wilson SR, Frazier EA, Hayward AD. A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma. Am J Respir Crit Care Med. 2006;174(10):1077–1087. [PubMed: 16931634] doi:10.1164/rccm.200510-1606OC.
   PubMed Web of Science ®Google Scholar
• Bates CA, Silkoff PE. Exhaled nitric oxide in asthma: from bench to bedside. J Allergy Clin Immunol. 2003;111(2):256–262. [PubMed: 12589342] doi:10.1067/mai.2003.103.
   PubMed Web of Science ®Google Scholar
• Heaney LG, Busby J, Bradding P, Chaudhuri R, Mansur AH, Niven R, Pavord ID, Lindsay JT, Costello RW. Medical research council UK Refractory Asthma Stratification Programme (RASP-UK). remotely monitored therapy and nitric oxide suppression identifies nonadherence in severe asthma. Am J Respir Crit Care Med. 2019;199(4):454–464. [PubMed: 30339770] doi:10.1164/rccm.201806-1182OC.
   PubMed Web of Science ®Google Scholar